It is known that malignant pleural effusion (MPE) is one of the most deleterious hazards of cancers from which most patients become annoyed mainly from the discomfort of dyspnea that can interfere with life quality and compel the affected persons to repeatedly seek medical advice asking mainly about how to get rid of the effusion permanently and to prevent the recurrence.
Background
It is known that malignant pleural effusion (MPE) is one of the most deleterious hazards of cancers from which most patients become annoyed mainly from the discomfort of dyspnea that can interfere with life quality and compel the affected persons to repeatedly seek medical advice asking mainly about how to get rid of the effusion permanently and to prevent the recurrence. Aims The target of the discipline is comparing the effectiveness and safety of thoracoscopic pleurodesis by talc, doxycycline poudrage, and silver nitrate (SN) slurry in patients with MPE. Patients and methods Forty-five patients with MPE eligible for pleurodesis were randomly chosen and divided into three groups, with 15 patients each, for 1-g doxycycline poudrage (group I) or 4-5 g of sterilized medical talc powder (group II) or 50 ml SN 1% (group III) through thoracoscopy using spraying catheter. The results were compared among the three groups. Results A total of 20 patients had bronchogenic carcinoma in groups I, II, and III (53.3, 46.7, and 33.3%, respectively) and breast cancer was seen in nine patients (26.6% of both groups I and II and 33.3% of group III). Conclusion Talc, doxycycline poudrage, and SN slurry are approximately equal regarding the Introduction Malignant pleural effusion (MPE) is known to be a common complication of malignancies, which is up to expectations, and is associated with a very high mortality rate [1] The patient lifestyle becomes deteriorated mainly from dyspnea to the degree that patients cannot do self-hygiene independently for fear of dyspnea and respiratory distress. Various therapeutic plans were done to overcome the high recurrence rate of MPE such as pleurodesis using various agents, intrapleural catheter, and repeated thoracocentesis, and pleurodesis is the most common plan used [2, 3] .
Up till now, there is no ideal sclerosing agent because the ideal one must be safe, effective, cheap, available, and well tolerated by the patient regarding being free from significant adverse effects that might be fatal, such as acute respiratory distress syndrome. So, each pleurodesing agent has its advantages and disadvantages. Examples of these agents include talc, tetracyclines, doxycycline, bleomycin, silver nitrate (SN), povidone-iodine, etc. [4] .
The choice of the pleurodesing agent depends on its availability, price, patient characteristics, and facilities of each center [5] .
Thoracoscopy-guided pleurodesis could be done if the pleura seems to be abnormal, and consequently, the patient benefits from diagnostic and therapeutic intervention in a single session [6] .
Thoracoscopy also can aid in diagnosing patients with highly recurrent undiagnosed exudative effusions as it can explore the pleural layers and take biopsies from suspicious lesions for histopathology and also can promote lung expansion by performing adhesiolysis [7, 8] .
The current study compares between pleurodesis results by talc, doxycycline poudrage, and SN slurry by thoracoscopic spraying of each pleurodesing agent.
Studies of comparison between different pleurodesing agents are minimal in the literature, so the current study aimed to compare among these chemicals regarding efficiency and safety [9] [10] [11] .
Considering the patient life quality and the choice of the most suitable technique with the least drawbacks and the most effective result, the study aimed to determine which of these chemical agents could perform efficient and safe pleurodesis, and which of them is superior [11, 12] .
Talc powder can be bought with difficulty, as it is not available in Egypt, but it is very safe and very effective in pleurodesis [8, 13, 14] .
Doxycycline has been involved in many types of researches for pleurodesis of MPEs and also for recurrent pneumothorax [8] .
The mechanism of SN in pleurodesis is owing to inflammatory reaction with the pleural mesothelium that eventually ends with fibrosis and pleural space closure, and this was justified in many preparatory but small number of clinical trials [11, 13] .
Patients and methods
It is a randomized control double-blind study in which all participants were asked to be included voluntarily in the study after taking a recorded approval before involvement in the study, guided by the rules of Alexandria Faculty of Medicine committee of ethics.
Criteria of the included and excluded patients were as follows:
Inclusion criteria
(1) Improved respiratory symptoms especially dyspnea after pleurocentesis. (2) Trapped lung.
(3) Patients with a history of previous pleurodesis or radiotherapy to the affected site.
The following was done to the involved participants: history taking, including personal data, occupation, smoking index, history of other diseases, and the presenting symptoms; clinical examination (general and chest); routine investigations, including complete blood count with differential cells, Creactive protein, renal function tests, arterial blood gases, prothrombin activity, and the international normalized ratio; and radiological evaluation, including chest roentgenography and computed tomography.
Sterilization of the site of pleurocentesis previously marked by ultrasound was done, followed by infiltration of 3 cm of lidocaine 2% starting from the skin and subcutaneous tissue up to pleural space. Then introduction of 18 G needle and aspiration of three samples for chemical analysis (protein, glucose, LDH, cells), bacteriological culture, and cytological analysis of the fluid were done. All included patients underwent ultrasoundguided medical thoracoscopy (Karl Storz, Germany) with autoclavable spraying catheter. The intervention was performed while the patient was consciously sedated by intravenous injection of midazolam 5 mg. The entire lateral chest wall was scrubbed with iodopovidone and then local anesthesia of the skin and subcutaneous tissue by lidocaine 2% was done. After that 2-cm transverse incision of the skin and blunt dissection of subcutaneous tissue and intercostal muscles were done, followed by trocar insertion. The pleural fluid was gradually removed by a small suction tube. The exploration of the pleural cavity was then done by the rigid thoracoscope. After taking a full view of the pleura, mechanical adhesiolysis was done for the adhesions (if any), and 4-6 forceps biopsies were taken from the abnormal posterior costal and diaphragmatic parietal pleural lesions. Pleural biopsies were subjected to histopathological analysis, and pleurodesis was done using one of the different sclerosing agents previously chosen by double-blind randomization, in which the pleurodesing agent was widely sprayed onto the pleura by the spraying catheter:
Group I: The particles of 10 mg/kg doxycycline capsules [8] .
Group II: The particles of 4-5 g of sterilized medical talc powder [9] . Group III: A solution of 50 ml SN 1% [10, 12] .
For the three groups after finishing the procedure, 28-F intercostal tube was inserted at the track of the thoracoscope, and it was removed when the amount of the daily drained fluid is lower than 150 ml. There was no evidence of air leakage, and the lung showed adequate radiological expansion.
All patients in the three groups were monitored for postprocedure adverse effects. Clinical and radiological monitoring was done after a week, a month, and 3 months following the procedure, and the clinical response of the patients was considered as complete (if no fluid recurrence), partial (if recurrence of small effusion not requiring further intervention), or failure (if recurrence of the effusion is requiring further intervention). The procedure was well tolerated without major adverse effects, and some minor adverse effects occurred like chest pain in nearly all patients (n=43), and pain visual analog scale (VAS) was used to compare among the three groups, with a resultant statistically significant difference among the three groups, as pain VAS was higher in the group I than group II (P 1 =0.014), whereas pain VAS was statistically insignificant between group III in comparison with Comparison among the three studied groups according to age (years).
Results
group I and group II (P 2 =0.101, P 3 =0.210). Regarding fever, there was a statistically significant difference between groups I and II, with a higher percentage in group I than group II (P 1 =0.034), and was statistically insignificant in group III in comparison with group I and group II (P 2 =0.218 and P 3 =0.644, respectively) ( Table 1) .
Other complications included surgical emphysema (n=8) (33.3, 13.3, and 6.7% in groups I, II, and III, respectively), fever (n=13) (53.3, 20, and 13.3% in groups I, II, III respectively), and pneumothorax (n=7) (40% of both groups I and II and 6.7% of group III), with insignificant difference among the three groups (P>0.05).
After follow-up of patients in the first month, lung expansion was complete in 36 patients (73.3, 93.3, and 73.3% of groups I, II, and III, respectively) and partial in four patients (6.7, 6.7, and 13.3% of groups I, II, and III, respectively), whereas failed pleurodesis was noticed in 33.3% of both groups I and III, with a statistically insignificant difference among the three groups (P>0.05) ( Figure 2 ).
Postthoracoscopic hospital stays in groups I, II, and III averaged 2.47±1.06, 2.33±0.49, and 2.73±1.39 days, respectively, but patients of group I stayed in hospital longer than group II, with a statistically significant difference (P 1 =0.094), whereas those in group III stayed longer than group II, with statistically significant difference (P 3 =0.090), and there was no significant difference between patients of groups I and III ( Table 2) .
Immediate recurrence occurred in 20 and 13.3% of groups I and III, whereas late recurrence of effusion occurred in 13.3, 6.7, and 26.7% of groups I, II, and III, respectively, with insignificant difference among the three groups regarding immediate or late recurrence (P>0.05).
Dyspnea of nearly all patients improved from a preprocedure worse degree in Borg scale to a better VAS, visual analog scale.
Figure 2
Comparison among the three studied groups according to lung expansion.
one after pleurodesis, except for those with a failed procedure. In 37 cases, dyspnea Borg scale was from one to three in the three groups I, II, and III (80, 93.3, and 73.3%, respectively), and only three cases had dyspnea Borg scale of six to eight in groups I and III (20% of both groups I and III), and there was an insignificant difference in postthoracoscopic Borg scale among the three groups (P 1 =0.600, P 2 =1.000, and P 3 =0.402) (Figure 3 ).
Discussion
MPE is known to be a very common drawback of malignancies in which most patients complain of progressive dyspnea that can interfere with the patient daily activities, and the patient becomes anxious mainly about the high recurrence of the problem in addition to the poor overall 6-month survival of the patient once diagnosed [1] [2] [3] . Pleurodesis is the most widely accepted method for palliative management. The current discipline involved studying the potency and the drawbacks of doxycycline, talc poudrage, and SN slurry in pleurodesis for MPE. The results denoted that the three agents were different regarding efficacy and adverse effects [4] [5] [6] .
Medical thoracoscopic spraying of the sclerosing agent allows it to be widely dispersed into the pleural cavity, so as to improve the efficacy and safety of the treatment [7, 9, 15] . For effective and successful pleurodesis to occur, adequate apposition between two pleural layers must be achieved which can be visualized during thoracoscopy [13, 14] . However, there are few reports comparing the efficacy and safety of this technique by the three agents in treating MPE caused by different types of cancers. Shouman et al. [15] have indicated that the availability and cost of the sclerosing agents are the most significant factors that determine the choice of Significance P 1 =0.094, P 2 =1.000, P 3 =0.090
MC, Monte Carlo. P: P value for comparing between the three studied groups. P 1 : P value for comparing between groups I and II. P 2 : P value for comparing between groups I and III. P 3 : P value for comparing between groups II and III.
Figure 3
Comparison among the three studied groups according to postthoracoscopic Borg scale.
any of them in many centers of the developing countries.
The current study proved that thoracoscopy is successful in reaching the diagnosis of undiagnosed exudative effusion by taking biopsies from the highly suspected pleural lesions and additionally important in the on-table pleurodesis [8, 14] .
Exudative effusions that have a high suspicion of malignancy can be diagnosed by medical thoracoscopy and also patients gained benefit from pleurodesis at the same session, and this is one of the considerable blessings of that method concerning thoracoscopic pleurodesis [16] .
After doing thoracentesis in six cases of our study in which the effusion was recurring in a high rate, the results were disappointing regarding reaching the cause, but after thoracoscopic biopsy, two of them were diagnosed as mesothelioma in the SN group and four were diagnosed as adenocarcinoma in the doxycycline group, and they underwent pleurodesis in the same session as the posterior costal and diaphragmatic pleurae were infiltrated with highly suspicious masses, which were confirmed later by histopathological examination [15] .
In this study, breast cancer and bronchogenic carcinoma were responsible for most of MPE in the three studied patient groups, and this result was comparable to those detected in previous similar trials in which approximately 75% of MPE cases were owing to pleural metastasis from bronchogenic carcinoma and cancer breast. Similarly in another trial, in more than half of the cases of MPE, carcinomas of lung and breast were the main sources of malignancy [17] .
The failure rate of pleurodesis in doxycycline and SN groups was 20 and 13.3%, respectively, whereas the talc group showed that all patients had successful pleurodesis, and our results were approximately similar to the rates reported in previous studies [18] . Minor hazards have been documented in the current study of which the most frequent were postthoracoscopic pain and pyrexia, especially the doxycycline group, which had a statistically significant value in comparison with talc, as pain VAS was higher in the doxycycline group than talc group (P 1 =0.014), whereas SN group showed no statistically significant difference in comparison with the talc group and with doxycycline group (P>0.05). Pain and fever were the most reported complications following the use of different sclerosing agents still like variable strategies of administration as incontestable within the five English-speaking countries' survey done by Lee et al. [19] .
Hazards of the pleurodesis procedure were not fatal and resolved spontaneously and with the aid of NSAIDs, antibiotics, and chest tube insertion at a superior intercostal space also with oxygen therapy, and encouraging those patients for mobilization (for pneumothorax and surgical emphysema).
Postthoracoscopic dyspnea Borg scale in our study was from one to three in more than 50% of the cases in the current study, which demonstrates the great benefit of the procedure regarding dyspnea, which is the most annoying symptom to the patients, and there was no statistically significant difference among the three groups (P>0.05).
After finishing pleurodesis, 24-F chest tube was inserted, and the patients stayed in the hospital to observe lung expansion and to pay attention to diagnosing and treating minor complications of the procedure. Most of our patients stayed in the hospital for only 2 days in the three groups (80, 66.7, and 73.3% of groups I, II, and III, respectively), but patients of doxycycline group stayed in hospital longer than patients in talc group, with statistically significant difference (P 1 =0.094), whereas those in SN group stayed longer than group II, with statistically significant difference (P3=0.090), and there was no significant difference between patients of doxycycline group and SN group.
The current study results regarding doxycycline poudrage agree with those of the study done by Elnady and Sakr, which involved the safety and efficacy of pleurodesis with thoracoscopic doxycycline poudrage in MPE, and they found that 74.1% of patients had successful pleurodesis that is approximately similar to our study in which complete lung expansion occurred in 73.3% after 1-month follow-up. They concluded that doxycycline is cheap, well-tolerated, reasonably effective, comparatively simple, and safe and is able to improve respiratory symptoms [20] .
Hashemi et al. [21] demonstrated that SN is comparable to tetracycline regarding potency for MPE palliative treatment. Other advantages of SN are its low price, safety, and being easily reachable.
The main obstacle faced us was the small number of participants, which is consistent with the previous few trials in that field, together with that a part of these trials were animal studies. Price and availability also were different among the three agents, as talc is very expensive and not available in Egypt, whereas doxycycline and SN are available and cheap. Our study showed that SN and doxycycline were effective with minor postpleurodesis complications and low recurrence rate, so they can be used in our setting.
Conclusions
Talc, doxycycline poudrage, and SN slurry are approximately equal regarding the improvement of dyspnea and postthoracoscopic hospital stay. A higher number of cases are recommended for further assessment, and the study proves the saying that the ideal sclerosing agent is not available up till now.
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